Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37288883

about

Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.Quantitative Analysis of Immunohistochemistry in Melanoma Tumors.Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Increased shedding of HU177 correlates with worse prognosis in primary melanoma A role for the retinoblastoma protein as a regulator of mouse osteoblast cell adhesion: implications for osteogenesis and osteosarcoma formation Diagnostic and prognostic biomarkers in melanoma.Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.Utilisation of search filters in systematic reviews of prognosis questions.Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.Mucins as diagnostic and prognostic biomarkers in a fish-parasite model: transcriptional and functional analysis Expression of vitamin D receptor decreases during progression of pigmented skin lesions.Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer.Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma Stage-specific prognostic biomarkers in melanoma Fad104, a positive regulator of adipocyte differentiation, suppresses invasion and metastasis of melanoma cells by inhibition of STAT3 activity.CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.Using global gene expression to discriminate thin melanomas with poor outcomes.SNPs at miR-155 binding sites of TYRP1 explain discrepancy between mRNA and protein and refine TYRP1 prognostic value in melanoma.Revisiting determinants of prognosis in cutaneous melanoma.Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis.Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.Established and Emerging Biomarkers in Cutaneous Malignant Melanoma.Germline determinants of clinical outcome of cutaneous melanoma.C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients Melanoma prognostic model using tissue microarrays and genetic algorithms.Construction and analysis of multiparameter prognostic models for melanoma outcome Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

P2860

Q28067140-5676BE0F-4B4C-465B-B9D9-1A0F3B0DE10D Q28728722-BFCAE9A8-4023-4623-874A-B3A272ACA615 Q28751824-51067477-30D4-4C41-8CD7-8C19FF277166 Q30252150-56980E47-F99F-4CEB-9B2F-625346525997 Q30514241-AA16330F-F77C-43F5-8245-06BEAB231520 Q30982790-EE2773B7-0C38-4175-A040-6E40892BAA9E Q33557480-590D8E2E-1853-449C-9DD8-8222A20700AD Q33597204-D8E2E213-775D-447B-B428-86F3C324D68C Q33688711-83F5625F-D7FB-4856-A0EE-D9B6CB4EE157 Q33724016-A6D82DB8-90EC-452A-A7F3-BC486ED3DB80 Q33750138-B45562D4-F121-4BAA-BDD2-8AA6F86B51BF Q33862470-088BFC2C-26FD-47EA-BA7C-EC07FA9AEDC1 Q33954883-DE14F016-2C5F-4672-8E38-F939C394A323 Q34313600-453A5806-3A17-4BCE-8C18-9D16A15B729B Q34482829-DD3D5A1D-085B-42D2-B1F9-80A67915386C Q34486542-51A709AF-502D-4131-B109-619908165111 Q34708265-F7B479D5-F0AF-483A-BCF8-8F2614B939C7 Q34775719-4F520FFD-E3E8-4326-9201-5D9B67558DD5 Q34803691-CDB2BE5E-2B22-4C58-ADEB-3717E336D294 Q34842139-3C238BFE-EB65-4E0F-8C9A-C77E2CB6DD20 Q35037270-0DA5F696-3F5D-4424-9711-AAFFDE0852A9 Q35234354-EF4F242E-BBFA-47DC-BCC1-AA0628B7F1FD Q35551970-9D42D540-80A1-474A-8C05-13D58CE05F94 Q35559300-2C83B608-80B4-4816-AA1F-619EA88A6918 Q35924872-2251E6D8-F7A0-4B19-A836-2BD481BF8599 Q35977922-0841E7FA-C91B-47D2-BEF4-A66A024C6313 Q36264686-25272ECE-DEDF-43B0-B4C8-B8C0E02ACC1E Q36280622-FE5FC390-5F89-4168-BBF0-BB475A8B800C Q36286668-2636E6D1-B493-4992-951C-217DF7903ECC Q36338825-4D459463-8809-4384-876F-9DA2A7A09010 Q36356155-76CC878B-49AD-486B-960F-C75625C1467C Q36783370-A5C9C52A-7C90-4F05-95C7-F863D1E1AAFB Q37069223-385D64EA-A6FA-427B-A162-845AB98CA326 Q37258423-22A19220-0316-4AFA-AA29-2EB4D9B62133 Q37288405-91255902-6B14-4AD3-A3F2-43B3D2845907 Q37474252-4B134DCE-2102-4413-BA48-A60CB3DB5DCE Q37550749-A1CB63FF-7A60-4CA1-8ED3-03FB4204F602 Q37565391-81E3E4B5-EC31-4E46-9F9A-429F1992B40B Q37605787-6295B052-FEB5-4BA9-9112-9189855D6DC4 Q37658459-060782C0-6F8A-4F80-8A34-3F3F5FC884D2

P2860

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q37288883

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@en

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@nl

type

label

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@en

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@nl

prefLabel

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@en

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@nl

P1433

Q37288883-C3000BCF-BCEA-450A-8572-745D7B93ABDC

P1476

Q37288883-7B5CED90-CD40-4BAB-844C-BD72D1A57EC9

P2093

Q37288883-84A96156-AD1E-48F6-809C-4AA8BEDE12D5

Q37288883-A430131B-5A1D-4A35-A122-9A94AE11BB47

Q37288883-DCCC948C-A9D3-4E32-B270-34877F96150B

P2860

Q37288883-01DF7E91-F45D-45ED-8B4E-6221A9C15391

Q37288883-04630ABD-8FB4-4C0B-A228-D6673AA51860

Q37288883-0B6FECF2-EF44-4E11-950F-01C2AAF2DB2A

Q37288883-0B81DF0F-9E24-41CE-B80C-48180E253DE0

Q37288883-0D12F734-7F73-48F9-9A36-C74F905110A6

Q37288883-0E639B5C-8B81-4025-AFE5-C04777A459FB

Q37288883-0F098CFD-3752-4ABB-8812-A0E5A7A33218

Q37288883-0F0E0BE4-4EEE-4C2F-82AB-C340EFD1016B

Q37288883-0FF17685-057D-420B-AADC-5B87B182B01F

Q37288883-1022A9BD-4A1F-4CA1-AD07-662E65DE99F5

P304

Q37288883-43A6574B-38EC-4DB4-BF95-193E33962729

P31

Q37288883-0EEF5518-CAE5-437E-A31A-7B3F2850154A

Q37288883-76b629a0-1338-4277-a02c-6f911d132a57

P356

Q37288883-CD394001-63AE-45FC-8660-A0181FFE89FA

P407

Q37288883-733734B2-6901-4AF7-9A25-897BAD019C85

P433

Q37288883-39B17411-AC52-48EE-BB39-4FE2E57019B9

P478

Q37288883-A75D886E-0B6A-4DE0-BB9E-98C92FF48CA0

P577

Q37288883-F93E2E19-979D-483C-93DF-2F161EFE6F4E

P5875

Q37288883-BA52CC0C-998F-496C-B62B-39C80472604E

P698

Q37288883-4D0417AC-B5FC-4B56-A070-FEE1913D2559

P921

Q37288883-1D6971E6-FEDB-44B7-9517-08BC43651022

Q37288883-D885DED9-F62A-411C-93AA-4F47C21289C8

P932

Q37288883-EEBC1F22-F4E7-4619-BF78-834957B43CD7

P356

P1433

Journal of the National Cancer Institute

P1476

Tissue biomarkers for prognosi ...... atic review and meta-analysis.

@en

P2093

Bonnie E Gould Rothberg

http://www.w3.org/2001/XMLSchema#string

David L Rimm

http://www.w3.org/2001/XMLSchema#string

Michael B Bracken

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

Nuclear ING2 expression is reduced in human cutaneous melanomas

Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.

Cancer statistics, 2008

Measuring inconsistency in meta-analyses

Gene expression profiling predicts clinical outcome of breast cancer

Meta-analysis in clinical trials

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

P304

452-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJP038

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24231610

http://www.w3.org/2001/XMLSchema#string

P698

19318635

http://www.w3.org/2001/XMLSchema#string

P921

P932

2720709

http://www.w3.org/2001/XMLSchema#string